托瑞米芬与他莫昔芬治疗进展期乳腺癌的系统评价.pdfVIP

1026 ( J F urth M ilM ed Univ) 2009, 30( 11) http: / /www. fmmuxb. cn : 2009) 1, 2 1 2 2 1, 2 马 文 , 王小虎, 杨克虎 , 田金徽 , 刘锐锋 1 2 ( , 730050, , 730000) Torem ifene and tamoxifen for patients gr up, and the quality f life w as smi ilar in the 2 gr ups. CONCLUSION: The results suggest that TOR has better effec with advanced breast cancer: A meta tiveness and safety than TAM in mi pr ving the l ngterm survival analysis of randomized controlled trials rate f r patients w ith advanced breast cancer. 1, 2 1 2 2 MA W en , WAN G X iaoH u , YAN G K eH u , TIAN J inH ui , Keywords! breast ne p lasm s; end crine therapy; T am x ifen; LI U R uiF eng 1, 2 T rem ifene; system atic review 1 Departm ent f Rad i therapy, Cancer H sp ital f Gansu Pr vince, Lanzh u 730050, China, 2 EvidenceB ased M edicine Center, ! : ( TOR ) ( TAM ) Lanzh u Un iversity, Lanzh u 730000, China . : PubM ed, CBM disc, C chrane L ibrary, Abstract! AIM: T evaluate the clin ical effectiveness and safety , , , f t rem ifene( TOR) versus tam x ifen ( TAM ) f r patients w ith . TOR advanced breast cancer. METHODS: This study retrieved rele TAM , 200806. vant rand m ized c ntr lled trials in PubM ed, EMBASE, C chrane C ch rane 4. 2. 6, 2 Library, Ch inese B i m ed ical Literature Database, Ch inese Scien , , tific J urnal Fu lltext Database, and Chinese J urnal Fu lltext RevM an4. 2. 10 M eta,